New study concludes that PFS is a very real risk for anyone taking finasteride:
“There is a high statistically significant risk of all measured outcomes – impotence, phosphodiesterase 5 (PDE5) inhibitors, and diminished libido in men younger than 42 who were prescribed finasteride at a dose of less than or equal to 1.25 mg/day for androgenic alopecia compared to men who had no exposure to a 5-alpha reductase inhibitor,” Tina Kiguradze, of the Feinberg School of Medicine at Northwestern University in Chicago, and colleagues concluded in a poster presentation.
The story here: